CCR9 and inflammatory bowel disease: By blocking physiologic CCL25/CCR9 interactions using CCL25‐conjugated Sepharose beads, intestinal inflammation was found to be alleviated in IBD patients by selectively deleting CCR9+ monocytes.22, 23